Clinical Trials Directory

Trials / Unknown

UnknownNCT00817726

RBD Longitudinal as Prognostic for PD

A Natural History Analysis of Rapid Eye Movement Sleep Behavior Disorder as Prognostic for Parkinson's Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
164 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Accepted

Summary

* Purpose - to validate a combination of biological and clinical markers in the rapid-eye-movement (REM) sleep behavior disorder (RBD) population as indicative of the pre-symptomatic stage of Parkinson's disease (PD). * Procedures - All subjects (RBD diagnosis and controls) will have 1) a medical and neuro history and physical including videotape of movements, 2) neuropsychological testing, 3) a sleep study, 4) olfactory testing, 5) blood draw for serum testing , 6) functional MRI. All of these procedures are often performed clinically in the diagnosis of PD. Enrollment of subjects with PD is complete. Any testing performed prior to enrollment as part of the clinical evaluation may be used in place of repeating the procedure for the study. Subjects will be followed for 5 years. It is hypothesized that a 5 year follow up may capture a significant number of pre-Parkinson's subjects who will be diagnosed. Subjects may be offered a repeat enrollment after 5 years.

Detailed description

Enrollment of PD and PS cohorts is complete. Currently enrolling only confirmed RBD and Controls.

Conditions

Timeline

Start date
2009-01-01
Primary completion
2024-12-01
Completion
2025-05-01
First posted
2009-01-06
Last updated
2023-11-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00817726. Inclusion in this directory is not an endorsement.